Source link : https://www.newshealth.biz/health-news/can-we-repurpose-obesity-drugs-to-reverse-liver-disease/
Metabolic dysfunction–associated steatotic liver disease (MASLD) has become the most common liver disease worldwide, with a global prevalence of 32.4%. Its growth over the past three decades has occurred in tandem with increasing rates of obesity and type 2 diabetes — two cornerstones of MASLD. Higher rates of MASLD and metabolic dysfunction–associated steatohepatitis (MASH) with […]
Author : News Health
Publish date : 2024-10-28 10:52:31
Copyright for syndicated content belongs to the linked Source.
